Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

STORY: U.S. stocks ended mixed on Tuesday as investors gauged the latest inflation data and braced for quarterly earnings ...

Most U.S. stocks rose following an encouraging update on inflation, but drops for Eli Lilly and some other influential stocks ...

The only stock to drag more on the market was Eli Lilly, which fell 6.6% after saying ... CEO David Ricks said last quarter’s 45% growth in Lilly’s revenue for its Mounjaro diabetes treatment, ...

Cool wholesale inflation numbers provide only slight relief before Wednesday's release of December Consumer Price Index data.